Champions Oncology Profit Margin

Champions Oncology (CSBR) currently reports a profit margin of -15.16% as of January 2026. That compares with 37.85% in the prior-year period — down 140.1% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Champions Oncology's profit margin history and peer comparisons.

Champions Oncology's profit margin decreased from 37.85% to -15.16% — a 140.1% year-over-year decrease (period ending January 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Champions Oncology's profit margin of -15.16% is lower than the Healthcare sector average of 15.58%. That is roughly 197.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Champions Oncology's current -15.16% should be judged against Healthcare norms (sector average: 15.58%) and against CSBR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -15.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Champions Oncology, and consider following CSBR for alerts when major investors trade the stock.